Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

151 Confirmed Safety of Deutet.rabenazine for Tardive Dyskinesia in a 3-Year Open-Label Extension Study

Hubert H Fernandez,Hadas Barkay,Robert A Hauser,Stewart A Factor,Joohi Jimenez-Shahed,Nicholas Gross,Leslie Marinelli,Mark Forrest Gordon,Juha-Matti Savola,Karen E Anderson

CNS spectrums（2020）

Cited 1|Views35
No score
Abstract
These results support the safety outcomes observed in the ARM-TD and AIM-TD parent studies and the safety of deutetrabenazine for long-term use in patients with TD.Funding Acknowledgements: This study was funded by Teva Pharmaceuticals, Petach Tikva, Israel.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined